<DOC>
	<DOC>NCT00681772</DOC>
	<brief_summary>Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The aim of this study was to investigate safety, tolerability and efficacy of vardenafil following a flexible dose treatment schedule in subjects with varying aetiology.</brief_summary>
	<brief_title>Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Men &gt;/= 18 years of age, ED 6 months or longer Stable sexual relationship for &gt; 6 month. Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within prior 6 month Nitrate therapy Other exclusion criteria apply according to the Summary of Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Vardenafil</keyword>
</DOC>